CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
61.29
-0.59 (-0.95%)
At close: Mar 9, 2026, 4:00 PM EDT
62.49
+1.20 (1.96%)
After-hours: Mar 9, 2026, 7:34 PM EDT
CG Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5,175 | 3,349 | 2,183 | - | - | - |
| Market Cap Growth | 140.88% | 53.40% | - | - | - | - |
| Enterprise Value | 4,442 | 2,676 | 1,643 | - | - | - |
| Last Close Price | 61.88 | 41.52 | 28.68 | - | - | - |
| PS Ratio | 1281.58 | 829.03 | 1916.94 | - | - | - |
| PB Ratio | 6.63 | 4.45 | 2.98 | - | - | - |
| P/TBV Ratio | 6.98 | 4.51 | 2.98 | - | - | - |
| EV/Sales Ratio | 1099.61 | 662.44 | 1442.48 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0 | 0.00 | 0.13 | 0.38 |
| Net Debt / Equity Ratio | -0.98 | -0.98 | -1.01 | -1.01 | -1.02 | -0.96 |
| Net Debt / EBITDA Ratio | 3.88 | 3.88 | 6.47 | 3.38 | 3.62 | 3.06 |
| Net Debt / FCF Ratio | 5.55 | 5.55 | 9.40 | 4.10 | 4.28 | 2.80 |
| Asset Turnover | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | - |
| Quick Ratio | 24.09 | 24.09 | 34.73 | 13.17 | 9.32 | 8.97 |
| Current Ratio | 24.63 | 24.63 | 35.30 | 13.62 | 9.54 | 9.78 |
| Return on Equity (ROE) | -21.67% | -21.67% | -19.18% | -31.36% | -42.85% | - |
| Return on Assets (ROA) | -15.42% | -15.42% | -15.02% | -19.97% | -21.34% | - |
| Return on Capital Employed (ROCE) | -25.10% | -25.10% | -15.60% | -30.00% | -26.60% | -23.90% |
| Earnings Yield | -3.11% | -4.81% | -4.03% | - | - | - |
| FCF Yield | -2.56% | -3.96% | -3.62% | - | - | - |
| Buyback Yield / Dilution | -23.69% | -23.69% | -1343.03% | -15.77% | -2.48% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.